The COVID-19 Clinical Research Coalition advances research driven by the needs of people in low-resource settings around the world. We are more than 900 scientific organizations and individuals from 98 countries, and we are leading, planning or participating in research and advocacy projects to benefit populations that haven’t been prioritized in the global research response to COVID-19. New members are always welcome – join us!

We leverage global expertise for high-impact COVID-19 research
Research areas
We champion equitable and affordable access to COVID-19 vaccines, diagnostics, and treatments
About us
We promote open sharing of research knowledge and data
Research based in low-resource settings is critical for an effective and truly global pandemic response. The community of researchers and scientists in the COVID-19 Clinical Research Coalition are up to the challenge, sharing their priorities, plans, and perspectives to advance locally led research for impact in the short and long term.
Dr Soumya Swaminathan
Chief Scientist, World Health Organization


Coalition membership currently includes 902 individuals from 98 countries, comprising 235 institutional members with 506 representatives from 69 countries, and 396 individual members from 82 countries.

See our members

Research areas

Our members are working on many projects, including Africa’s largest multi-country clinical trial to treat mild to moderate COVID-19; a review of the ethics of exclusion in vaccine trials; and studies on vaccine confidence in different populations. Some have joined expert working or advisory groups – see topic list below. Several of these groups have developed shortlists of priority research questions in low-resource settings.

Research areas


We have developed a library of resources and tools suggested by our working groups and individual members. We also maintain a searchable table of scientific publications on COVID-19 co-authored by members:

Explore our resources
Join the coalition
We are looking for individuals and institutions who want to lend their commitment and expertise to fast-track COVID-19 research in low-resource settings
Join us